Feghi Mostafa, Makhmalzadeh Sharif, Masihpour Nasrin, Amin Mansour, Mortazavinia Nader
Department of Ophthalmology, School of Medicine, Infectious Ophthalmologic Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Nanotechnology Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
J Ophthalmic Inflamm Infect. 2023 Oct 26;13(1):47. doi: 10.1186/s12348-023-00367-w.
Various organisms, such as bacteria, viruses, and fungi, can cause corneal ulcers. One of the leading causes of vision loss and disability worldwide is corneal ulceration. Practical, accessible, and affordable treatment for this disease seems essential.
Fifteen New Zealand rabbits infected with Staphylococcus aureus (ATCC 25923) corneal ulcers were randomly divided into three groups of five for the present study. (I, II, and III). Group I was used as the control group (without treatment). The second group received an iodine solution (1.25%) without a nanoparticle structure (betadine). The third group received an iodine solution with a nanoparticle structure used as eye drops. Drops in the corneal ulcer group were used five times daily for 14 days. Microbial counts and disease severity scores were measured on the first, second, fifth, and fourteenth days and compared between groups separately for each disease.
The results showed that the changes in microbial load were significant in the group that received betadine and nanoparticles. The microbial load was further reduced when using iodine nanoparticles than betadine. The betadine and nano-iodine groups significantly reduced the severity of the disease in rabbits with corneal ulcers (p < 0.05). The average changes in disease severity score were 4.8 ± 1.3, -2.6 ± 0.89, and -2.22 ± 1.22 in the untreated, nano iodine, and betadine groups, respectively. However, a significant increase in disease severity was observed in the untreated group (p = 0.001). It shows a significant difference (p < 0.001) between the nano iodine, betadine, and untreated groups. However, the difference in disease severity changes between nano iodine and non-nano iodine groups was insignificant.
Nanoparticle iodine is more effective than non-nanoparticle iodine in reducing bacterial load. In reducing the severity of the disease, both types of iodine were superior to no treatment. But there was no apparent difference between the two groups treated with iodine.
多种生物体,如细菌、病毒和真菌,均可导致角膜溃疡。角膜溃疡是全球视力丧失和残疾的主要原因之一。针对这种疾病的实用、可及且经济实惠的治疗方法似乎至关重要。
本研究将15只感染金黄色葡萄球菌(ATCC 25923)角膜溃疡的新西兰兔随机分为三组,每组5只(I组、II组和III组)。I组用作对照组(不进行治疗)。第二组接受无纳米颗粒结构的碘溶液(1.25%,聚维酮碘)。第三组接受具有纳米颗粒结构的碘溶液作为滴眼液。角膜溃疡组每天滴眼5次,持续14天。在第1天、第2天、第5天和第14天测量微生物计数和疾病严重程度评分,并针对每种疾病分别在组间进行比较。
结果显示,接受聚维酮碘和纳米颗粒的组中微生物载量变化显著。使用碘纳米颗粒时微生物载量比聚维酮碘进一步降低。聚维酮碘组和纳米碘组显著降低了角膜溃疡兔的疾病严重程度(p < 0.05)。未治疗组、纳米碘组和聚维酮碘组疾病严重程度评分的平均变化分别为4.8 ± 1.3、-2.6 ± 0.89和-2.22 ± 1.22。然而,未治疗组疾病严重程度显著增加(p = 0.001)。这表明纳米碘组、聚维酮碘组和未治疗组之间存在显著差异(p < 0.001)。然而,纳米碘组和非纳米碘组之间疾病严重程度变化的差异不显著。
纳米颗粒碘在降低细菌载量方面比非纳米颗粒碘更有效。在降低疾病严重程度方面,两种类型的碘均优于不治疗。但两组碘治疗之间没有明显差异。